Personalized Medicine and Epigenomics Market Report – Research, Industry Analysis Reports and Market Demands

Global Personalized Medicine and Epigenomics Market Growth (Status and Outlook) 2019-2024

Request for Sample of this report

Buy now

Table of Content

2019-2024 Global Personalized Medicine and Epigenomics Market Report (Status and Outlook)

1 Scope of the Report

2 Executive Summary

2.1 World Market Overview
- 2.1.1 Global Personalized Medicine and Epigenomics Market Size 2014-2024
- 2.1.2 Personalized Medicine and Epigenomics Market Size CAGR by Region
2.2 Personalized Medicine and Epigenomics Segment by Type
- 2.2.1 Reagents
- 2.2.2 Kits
- 2.2.3 Instruments
- 2.2.4 Enzymes
- 2.2.5 Services
2.3 Personalized Medicine and Epigenomics Market Size by Type
- 2.3.1 Global Personalized Medicine and Epigenomics Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Personalized Medicine and Epigenomics Market Size Growth Rate by Type (2014-2019)
2.4 Personalized Medicine and Epigenomics Segment by Application
- 2.4.1 Oncology
- 2.4.2 Non-Oncology
- 2.4.3 Cancer Drug Technology
2.5 Personalized Medicine and Epigenomics Market Size by Application
- 2.5.1 Global Personalized Medicine and Epigenomics Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Personalized Medicine and Epigenomics Market Size Growth Rate by Application (2014-2019)

3 Global Personalized Medicine and Epigenomics by Players

3.1 Global Personalized Medicine and Epigenomics Market Size Market Share by Players
- 3.1.1 Global Personalized Medicine and Epigenomics Market Size by Players (2017-2019)
- 3.1.2 Global Personalized Medicine and Epigenomics Market Size Market Share by Players (2017-2019)
3.2 Global Personalized Medicine and Epigenomics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Personalized Medicine and Epigenomics by Regions

4.1 Personalized Medicine and Epigenomics Market Size by Regions
4.2 Americas Personalized Medicine and Epigenomics Market Size Growth
4.3 APAC Personalized Medicine and Epigenomics Market Size Growth
4.4 Europe Personalized Medicine and Epigenomics Market Size Growth
4.5 Middle East & Africa Personalized Medicine and Epigenomics Market Size Growth

5 Americas

5.1 Americas Personalized Medicine and Epigenomics Market Size by Countries
5.2 Americas Personalized Medicine and Epigenomics Market Size by Type
5.3 Americas Personalized Medicine and Epigenomics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Personalized Medicine and Epigenomics Market Size by Countries
6.2 APAC Personalized Medicine and Epigenomics Market Size by Type
6.3 APAC Personalized Medicine and Epigenomics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Personalized Medicine and Epigenomics by Countries
7.2 Europe Personalized Medicine and Epigenomics Market Size by Type
7.3 Europe Personalized Medicine and Epigenomics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Personalized Medicine and Epigenomics by Countries
8.2 Middle East & Africa Personalized Medicine and Epigenomics Market Size by Type
8.3 Middle East & Africa Personalized Medicine and Epigenomics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Personalized Medicine and Epigenomics Market Forecast

10.1 Global Personalized Medicine and Epigenomics Market Size Forecast (2019-2024)
10.2 Global Personalized Medicine and Epigenomics Forecast by Regions
- 10.2.1 Global Personalized Medicine and Epigenomics Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
10.7 Global Personalized Medicine and Epigenomics Forecast by Type
10.8 Global Personalized Medicine and Epigenomics Forecast by Application

11 Key Players Analysis

12 Research Findings and Conclusion

Description

Epigenomics is the study of the complete set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The field is analogous to genomics and proteomics, which are the study of the genome and proteome of a cell.

According to this study, over the next five years the Personalized Medicine and Epigenomics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Personalized Medicine and Epigenomics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Personalized Medicine and Epigenomics market by product type, application, key companies and key regions.

This study considers the Personalized Medicine and Epigenomics value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Reagents
Kits
Enzymes
Services
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Oncology
Non-Oncology
Cancer Drug Technology

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Affymetrix
Agilent Technologies
Astellas Pharmaceuticals
BAYER AG
Bio Vision
Celgene Corp.
Emd Millipore
Epigenomics AG
Epigentex
Envivo Pharmaceuticals (Forum Pharmaceutricals)
Gilead Sciences
Glaxosmithkline
Illumina Inc.
Johnson & Johnson
Karus Therapeutics Limited
Laboratory Corp. Of America Holdings
LES Laboratoires Servier
Merck
Naturewise Biotech & Medicals Corp.
Novartis Pharma AG
Oncolys Biopharma Inc.
Orchid Chemicals & Pharmaceuticals Limited
Progen Pharmaceuticals Limited
Quest Diagnostics
Roche Holding AG
Rubicon Genomics
Takeda Pharmaceutical Company Limited

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Personalized Medicine and Epigenomics market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Personalized Medicine and Epigenomics market by identifying its various subsegments.
Focuses on the key global Personalized Medicine and Epigenomics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Personalized Medicine and Epigenomics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Personalized Medicine and Epigenomics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.